Skip to content
10-Q

Quarterly Report

NEUROMAMA, LTD.

0001517126-14-000027

← back to feed
Filed
Jan 17, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2013 · Jan 15, 2014 630.1M sh
Operating Cash Flow Q3 2013 · Oct 31, 2013 −$17K
Operating Cash Flow Q3 2013 · Oct 31, 2013 −$52.51K
Operating Cash Flow Q3 2013 · Oct 31, 2012 −$18.19K
Stockholders Equity Q3 2013 · Oct 31, 2013 $16.56M
Stockholders Equity Q3 2013 · Jan 31, 2013 −$9.72K
Current Liabilities Q3 2013 · Oct 31, 2013 $26.08K
Current Liabilities Q3 2013 · Jan 31, 2013 $14.44K
Total Liabilities Q3 2013 · Oct 31, 2013 $1.69M
Total Liabilities Q3 2013 · Jan 31, 2013 $14.44K
Current Assets Q3 2013 · Oct 31, 2013 $1.08K
Current Assets Q3 2013 · Jan 31, 2013 $4.72K
Total Assets Q3 2013 · Oct 31, 2013 $18.25M
Total Assets Q3 2013 · Jan 31, 2013 $4.72K
Sga Expense Q3 2013 · Oct 31, 2013 $309.58K
Sga Expense Q3 2013 · Oct 31, 2013 $422.96K
Sga Expense Q3 2013 · Oct 31, 2013 $424.81K
Sga Expense Q3 2013 · Oct 31, 2012 $3.11K
Sga Expense Q3 2013 · Oct 31, 2012 $3.53K
Net Income Q3 2013 · Oct 31, 2013 −$368K
Net Income Q3 2013 · Oct 31, 2013 −$500.81K
Net Income Q3 2013 · Oct 31, 2013 −$535.63K
Net Income Q3 2013 · Oct 31, 2012 −$4.61K
Net Income Q3 2013 · Oct 31, 2012 −$9.03K
Operating Income Q3 2013 · Oct 31, 2013 −$360.45K
Operating Income Q3 2013 · Oct 31, 2013 −$492.63K
Operating Income Q3 2013 · Oct 31, 2013 −$527.45K
Operating Income Q3 2013 · Oct 31, 2012 −$4.61K
Operating Income Q3 2013 · Oct 31, 2012 −$9.03K